Through its new strategic plan that is based on innovative procedures, the necessary infrastructure and cutting-edge technology, Henry Dunant is essentially creating a model oncology center, following all modern international standards and ensuring a holistic treatment of the oncology patient.
Starting with investing in prevention, Henry Dunant is developing a new vertically integrated process model that goes from the early diagnosis and staging of the disease to specialized treatment. To this end, the four Oncology Clinics of Henry Dunant, staffed by distinguished physicians and a team of specialized nurses, create a new core which is linked to the laboratory, diagnostic and surgical sectors, under the ongoing supervision of the Oncology Council, engaging all medical specialties involved and ensuring the personalized treatment of each patient.
This model is also served by several of the latest initiatives to upgrade the hospital’s technological equipment, such as the 4th generation Da Vinci Xi system, which ensures the performance of high-precision surgical procedures, the first and only digital PET/CT imaging system in private hospitals, which, among other things, significantly contributes to the early diagnosis, initial staging and planning of radiation therapy, as well as the state-of-the-art SPECT/CT for scintigraphy and monitoring the effectiveness of treatment.
In the field of technological equipment, a key role for the holistic treatment of oncological cases is played by the new radiotherapy department that is being created at the Henry Dunant, which will soon be equipped with a state-of-the-art linear accelerator, ensuring the three-dimensional irradiation of tumors in every area of the body and the simultaneous protection of healthy tissues.
It should be noted that two state-of-the-art radioactive iodine administration chambers (for thyroid cancer), as well as a state-of-the-art digital mammograph, certified by EUREF (European Reference Organization), equipped with a stereotactic biopsy system, are in operation at the Henry Dunant Hospital. In addition, based on modern international standards, an autonomous day-care area for chemotherapy has been created at Henry Dunant, while the operating theatres have been modernized, following the highest standards of quality and safety. Moreover, with the integration of Euromedica’s clinics and the creation of one of the largest private healthcare groups in Greece, Henry Dunant will be able to contribute to the integrated care of oncology patients in a considerable part of the country.
On the occasion of the new planning in the field of oncology, Roberto Greco, CEO of Henry Dunant, said: “Perhaps more than any other patient, the oncology patient requires an individualized therapeutic approach. The pace of technological developments is fast and constantly leading to new scientific methods. Henry Dunant is not a bystander but puts emphasis on the holistic treatment of each case, using every modern weapon, confident that this is the most effective way. We are investing and will continue to invest in this planning because we are investing in people and life."
